Scott Moss, the vice president and general manager of Dexcom Asia Pacific, discusses the recently announced dramatic expansion in funded access to continuous glucose monitoring and future developments in the management and treatment of insulin-dependent diabetes.

New Stories
-
Digital clinical trial recruitment platform in new agreements with patient groups
June 30, 2022 - Latest News -
Ramsay commits to 'science-based' decarbonisation targets
June 29, 2022 - Latest News -
Bupa Wellness supporting the health of 'The Big Issue' vendors
June 29, 2022 - Latest News -
Call for action to address low awareness of heart failure
June 27, 2022 - Latest News -
Teachers Health Group gives back $31 million from COVID savings
June 27, 2022 - Latest News -
HCF urges Australians to 'take stock' this end of financial year
June 27, 2022 - Latest News -
Bupa announces new opportunities for rural nursing leaders
June 22, 2022 - Latest News